Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hackshaw

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|May 23, 2013
A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancerM McCormack, L Kadalayil, A Hackshaw, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2025
Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trialG Eminowicz, S Vaja, D Gallardo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trialsP Wheatley-Price, F Blackhall, S-M Lee, et al.
Gynecologic Oncology|October 20, 2020
A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancerM R Hall, H-M Dehbi, S Banerjee, et al.
British Journal of Cancer|March 18, 2010
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumoursN C Turner, S J Strauss, D Sarker, et al.
Tobacco Control|March 1, 2005
Environmental tobacco smoke exposure in public places of European citiesM Nebot, M J López, G Gorini, et al.
Oncogene|May 16, 2017
Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancerM L Read, J C Fong, B Modasia, et al.
Journal of the National Cancer Institute|January 22, 2004
Tobacco and cancer: recent epidemiological evidenceP Vineis, M Alavanja, P Buffler, et al.
Pediatric Blood & Cancer|January 24, 2017
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)Brice Fresneau, A Hackshaw, D S Hawkins, et al.
Leukemia|January 28, 2017
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemiaC Rossig, M Pule, B Altvater, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|May 23, 2013
A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancerM McCormack, L Kadalayil, A Hackshaw, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2025
Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trialG Eminowicz, S Vaja, D Gallardo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trialsP Wheatley-Price, F Blackhall, S-M Lee, et al.
Gynecologic Oncology|October 20, 2020
A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancerM R Hall, H-M Dehbi, S Banerjee, et al.
British Journal of Cancer|March 18, 2010
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumoursN C Turner, S J Strauss, D Sarker, et al.
Tobacco Control|March 1, 2005
Environmental tobacco smoke exposure in public places of European citiesM Nebot, M J López, G Gorini, et al.
Oncogene|May 16, 2017
Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancerM L Read, J C Fong, B Modasia, et al.
Journal of the National Cancer Institute|January 22, 2004
Tobacco and cancer: recent epidemiological evidenceP Vineis, M Alavanja, P Buffler, et al.
Pediatric Blood & Cancer|January 24, 2017
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)Brice Fresneau, A Hackshaw, D S Hawkins, et al.
Leukemia|January 28, 2017
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemiaC Rossig, M Pule, B Altvater, et al.
Pageof 6